Related Experiment Video
Updated: Aug 16, 2025

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
Published on: August 4, 2018
Global Coagulation Testing in Acute Care Medicine: Back to Bedside?
Michael Caspers1,2, Johannes Fabian Holle3, Ulrich Limper4
1Department of Medicine, The Institute for Research in Operative Medicine, Faculty of Health, Witten/Herdecke University, Cologne, Germany.
Viscoelastic hemostatic assays (VHAs) offer rapid, bedside assessment of coagulation status, guiding goal-directed coagulation therapies (GDCT) in emergencies. VHA-based algorithms are increasingly used in trauma and bleeding management guidelines.
Area of Science:
- Emergency Medicine
- Hematology
- Critical Care
Background:
- Accurate coagulation status assessment is vital in emergencies.
- Conventional tests have limitations, especially with direct oral anticoagulants (DOACs).
- DOACs present diagnostic challenges in emergency settings.
Purpose of the Study:
- To review the evidence for viscoelastic hemostatic assays (VHAs) in guiding goal-directed coagulation therapies (GDCT).
- To focus on VHA-based GDCT in trauma and intracerebral bleeding/stroke management.
- To discuss the advantages and challenges of VHA use in emergency situations.
Main Methods:
- Qualitative review of current evidence on VHA-based GDCT.
- Focus on VHA application in specific clinical scenarios.
- Analysis of VHA advantages and limitations.
Main Results:
- VHA-based algorithms are increasingly incorporated into international guidelines for bleeding risk.
- VHAs provide rapid, bedside point-of-care information on hemostatic deficiencies.
- VHA-based GDCT offers a potential alternative to conventional coagulation testing.
Conclusions:
- VHA-based algorithms are recognized in guidelines for managing bleeding risks.
- VHAs facilitate faster, goal-directed hemostatic control in critical care.
- This review highlights VHA utility and challenges in trauma and stroke management.
More Related Videos
Related Concept Videos
Coagulation
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Acute Kidney Injury IV: Diagnostic Studies and Prevention

